Call Us On: +44 (0)161 6292129
Harke Group logo

Uniblue UDF2 – The Disinfectant Of The Future

Posted by Chemlink in Chemlink Lab, Chemlink Updates, Household Care Products, Regulations | 0 comments

20.07.20

Understandably, the world’s increased consumption of disinfectant is crucial at this time in order to safeguard us from COVID-19. Products with antimicrobial efficacy have never been more important, especially if they are proven to be effective against coronaviruses viruses like COV-SARS- 2, but there is – of course – an environmental secondary cost to consider. Today we’d like to introduce you to our revolutionary solution to a global problem, Uniblue UDF2.

Read more

Clariant BeautyForward 4

Posted by Chemlink in Chemlink Lab, Personal Care Products | 0 comments

09.07.20

Clariant’s regular beauty trends update was delivered by webinar last week, and focused on three key personal care trends: Fantasy Formulations, Embracing Ageing, and Active Beauty.

Read more

Sinerga’s COVID-19 Beauty and Personal Care Predictions

Posted by Chemlink in Chemlink Lab, Personal Care Products | 0 comments

09.07.20

The PC market is experiencing an unprecedented shake-up. Brands who had planned beauty and cosmetic formulations on projected trends are having to re-think their lines for the medium-term future due to the global pandemic which is changing behavioural and purchasing behaviours.

Read more

Plantasens Flash: Green Emollients From Clariant

Posted by Chemlink in Chemlink Lab, Personal Care Products | 0 comments

09.07.20

Plantasens® Flash 80 and 100 are two powerful alternatives to light emollients like D5 and isohexadecane that make light work of satisfying green beauty trends.

Read more

Customisable Sensorial Butters from Clariant

Posted by Chemlink in Chemlink Lab, Personal Care Products | 0 comments

09.07.20

Improve the sensory profile and spreadability of your personal care formulations with Plantasens® Sensorial Butters.

Read more

Clariant’s Sanitising Personal Care Ingredients For A Post COVID-19 World

Posted by Chemlink in Chemlink Lab, Personal Care Products | 0 comments

09.07.20

Over the course of this pandemic, consumer behaviours have markedly changed. Though this is entirely unsurprising on account of forced closures and lockdowns across the globe, adjusting to new patterns in the market can be troublesome for formulators. Gone are the days of testers, samples, and physical contact in the retail industry. Due to the social distancing that is now in place across all shopping avenues, these changes cannot be ignored.

Read more

Pharm-a-spheres

Posted by Chemlink in Pharmaceutical Products | 0 comments

01.07.20

Used extensively as an excipient for sustained-release pellets, sugar spheres and their characteristics open a world of possibilities.

Read more

Polycare® Split Therapy – When A Visit To The Hairdressers Isn’t An Option

Posted by Chemlink in Personal Care Products | 0 comments

04.06.20

The current global situation has put numerous industries in a position of uncertainty and change, and when this change occurs, it’s always an excellent idea to assess consumer patterns. Hairdressers and beauty salons have been closed for a long time, and it can be difficult to predict whether consumer habits will remain the same or shift entirely when trying to formulate appealing products.

Read more

Oral-Dispersible-Tablet Formulation Challenges

Posted by Chemlink in Chemlink Lab, Pharmaceutical Products | 0 comments

30.05.20

On Weds 27th May, Shilpa Mistry, our head of Pharma for UK and Ireland, delivered a webinar for Making Pharma on the challenges of formulating oral-dispersible-tablets (ODTs). In this blog we provide an overview of her presentation and the featured products for anyone who missed out on the webinar or who is looking for further details.

Read more

Register To Attend Shilpa Mistry’s ODT Formulation Webinar Now

Posted by Chemlink in Pharmaceutical Products | 0 comments

21.05.20

On the 27th May our Head Of Pharma UK and Ireland, Shilpa Mistry, will be presenting a webinar in the latest series published by the team at Making Pharma.

Read more

Scroll Up